Outbreak by KPC-62-producing ST307 Klebsiella pneumoniae isolates resistant to ceftazidime/avibactam and cefiderocol in a university hospital in Madrid, Spain.

Juan Antonio Castillo-Polo,Marta Hernández-García,María Isabel Morosini,Blanca Pérez-Viso,Cruz Soriano,Raúl De Pablo,Rafael Cantón,Patricia Ruiz-Garbajosa

The Journal of antimicrobial chemotherapy（2023）

引用 8|浏览7

暂无评分

摘要

The emergence of resistance to both ceftazidime/avibactam and cefiderocol in KPC-Kp-HRCs, together with the diversification of novel KPC enzymes displaying different antibiotic resistance phenotypes, is an epidemiological and clinical risk.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要